(2541466), M. Q., (15010), P. M., (104852), Y. Z., (95017), H. J., (22686257), L. G., (8495742), G. L., . . . (8665254), J. G. (2025). Table 1_Immune checkpoint inhibitor therapy in advanced cancer: Clinical association of irAEs type, inflammatory markers and efficacy.docx.
Citace podle Chicago (17th ed.)(2541466), Mengying Qian, Ping Ma (15010), Yu Zhao (104852), Hao Jiang (95017), LiYang Gao (22686257), Gaoyang Lin (8495742), Difan Duan (22686260), a Jinmin Guo (8665254). Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.
Citace podle MLA (9th ed.)(2541466), Mengying Qian, et al. Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.